BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hryhorowicz S, Kaczmarek-Ryś M, Zielińska A, Scott RJ, Słomski R, Pławski A. Endocannabinoid System as a Promising Therapeutic Target in Inflammatory Bowel Disease - A Systematic Review. Front Immunol 2021;12:790803. [PMID: 35003109 DOI: 10.3389/fimmu.2021.790803] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Mock ED, Gagestein B, van der Stelt M. Anandamide and other N-acylethanolamines: A class of signaling lipids with therapeutic opportunities. Prog Lipid Res 2022;:101194. [PMID: 36150527 DOI: 10.1016/j.plipres.2022.101194] [Reference Citation Analysis]
2 Shute A, Bihan DG, Lewis IA, Nasser Y. Metabolomics: The Key to Unraveling the Role of the Microbiome in Visceral Pain Neurotransmission. Front Neurosci 2022;16:917197. [DOI: 10.3389/fnins.2022.917197] [Reference Citation Analysis]
3 Srivastava RK, Lutz B, Ruiz de Azua I. The Microbiome and Gut Endocannabinoid System in the Regulation of Stress Responses and Metabolism. Front Cell Neurosci 2022;16:867267. [DOI: 10.3389/fncel.2022.867267] [Reference Citation Analysis]
4 Tortora C, Di Paola A, Argenziano M, Creoli M, Marrapodi MM, Cenni S, Tolone C, Rossi F, Strisciuglio C. Effects of CB2 Receptor Modulation on Macrophage Polarization in Pediatric Celiac Disease. Biomedicines 2022;10:874. [DOI: 10.3390/biomedicines10040874] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
5 Sionov RV, Steinberg D. Anti-Microbial Activity of Phytocannabinoids and Endocannabinoids in the Light of Their Physiological and Pathophysiological Roles. Biomedicines 2022;10:631. [DOI: 10.3390/biomedicines10030631] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]